The Food and Drug Administration has approved a fecal microbiota pill to treat recurrent infections caused by Clostridium difficile (C. diff), an antibiotic-resistant bacterium deemed an urgent threat ...

Nearly half a million people in the United States suffer from an intestinal infection called Clostridium difficile each year. Approximately half of those individuals become sick enough to require ...

At the end of 2010, Ellis Hospital noticed a troubling spike in Clostridium difficile infections. Clostridium difficile, or C-diff, is a common cause of diarrhea acquired in healthcare settings; it ...

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the ...

The National Institute for Health and Care Excellence (NICE) has recommended faecal microbiota transplant (FMT) as a treatment option for those with recurrent Clostridium difficile (C diff) infections ...

C. diff-associated diarrhea (CDAD) places financial stress on U.S. hospitals. A study of 170,000 discharges from 477 hospitals from 2009-2011 calculated that a CDAD case can increase a hospital stay ...

Clostridium difficile is an unpleasant, sometimes severe, and potentially lethal infection. It is an enteric pathogen whose armory involves the production of a toxin leading to gut dysphoria and ...

Clostridium difficile infection recurrence may increase the risk of death in patients, according to a presentation at the 27th European Congress of Clinical Microbiology and Infectious Diseases, held ...

The Infection Control Professionals of Southern New England provides a free, downloadable brochure on Clostridium Difficile infection. It also provides steps to properly wash hands with soap and water ...

A 70-year-old woman with a history of Clostridium difficile infection returned to the clinic with abdominal pain and diarrhea. Three stool samples were negative for C. difficile and WBCs. Would you ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Clostridium difficile infections market. The report includes a detailed analysis of the pipeline molecules ...

Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...